|
ZNF813 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.52979999948444E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.02619999997611E-06 |
| Normal-vs-Stage2 |
2.13909999999817E-05 |
| Normal-vs-Stage3 |
1.83749999993488E-07 |
| Normal-vs-Stage4 |
1.00749999454308E-08 |
| Stage1-vs-Stage2 |
7.514600E-01 |
| Stage1-vs-Stage3 |
5.070600E-01 |
| Stage1-vs-Stage4 |
3.468500E-02 |
| Stage2-vs-Stage3 |
8.712600E-01 |
| Stage2-vs-Stage4 |
1.354650E-01 |
| Stage3-vs-Stage4 |
1.275190E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15979999995675E-07 |
| Normal-vs-AfricanAmerican |
1.037620E-02 |
| Normal-vs-Asian |
3.04980000032096E-07 |
| Caucasian-vs-AfricanAmerican |
3.060600E-01 |
| Caucasian-vs-Asian |
4.811400E-01 |
| AfricanAmerican-vs-Asian |
2.578800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50610000027029E-07 |
| Normal-vs-Female |
1.48459999849138E-09 |
| Male-vs-Female |
3.402400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.65299999999036E-06 |
| Normal-vs-Age(41-60Yrs) |
2.67599999936863E-08 |
| Normal-vs-Age(61-80Yrs) |
1.49650000169643E-08 |
| Normal-vs-Age(81-100Yrs) |
1.917580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.917200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.631500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.390800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.379600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.192400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.766800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.180600E-03 |
| Classical-VS-Follicular |
6.985000E-01 |
| Classical-VS-Other |
3.700200E-01 |
| Classical-VS-Normal |
1.77670000001129E-06 |
| Tall-VS-Follicular |
5.015700E-02 |
| Tall-VS-Other |
8.850600E-01 |
| Tall-VS-Normal |
6.1341000057169E-09 |
| Follicular-VS-Other |
4.995200E-01 |
| Follicular-VS-Normal |
2.29149999997347E-06 |
| Other-VS-Normal |
9.255200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.04509999987457E-07 |
| Normal-vs-N1 |
5.46640000043119E-07 |
| N0-vs-N1 |
5.684000E-01 |
|
|
